MEET QPS AT THE WORLDSymposium™ 2024; February 4 - 9, SAN DIEGO, CALIFORNIA, USA

Lateral Lesion Tests

Lateral Lesion Tests

QPS Neuropharmacology offers a comprehensive battery of in-house validated behavioral tests to characterize lateral lesions in Parkinson´s disease models and supports the development of treatment strategies for this debilitating disorder. In our quest to understand Parkinson´s disease pathology and to test drug candidates, we employ induced models, such as the 6-hydroxydopamine (6-OHDA) lesion model, in which a unilateral lesion of dopaminergic neurons is induced, leading to a behavioral and biochemical asymmetry.

One way to evaluate lateral lesions is by assessing the asymmetry in motor performance between the lesioned and non-lesioned sides. With the cylinder test, quantification of forelimb use during rearing can be assessed while the corner turn test highlights side preferences since impaired animals favorable use limbs that are contralateral to the lesion side. To measure lateralized sensorimotor neglect the corridor test and corner turn test are utilized. These tests provide insights into the degree of asymmetry of unprompted motor behavior. In contrast, the rotation test requires the administration of dopaminergic agents, such as apomorphine or amphetamine, to exacerbate dopaminergic imbalance and cause unilaterally lesioned animals to turn vigorously. The number and direction of rotations are indicators of the severity and laterality of the lesion.

In addition to the behavioral characterization, histological or biochemical quantification of tyrosine hydroxylase (TH) and dopamine transporter protein (DAT) can be used to assess the degree of dopamine depletion in the lesioned hemisphere compared to the non-lesioned side.

By employing a combination of behavioral assessmentshistological examinations, and neurochemical analyses, the degree of lateral asymmetry, dopaminergic denervation, and axonal degeneration in induced Parkinson´s disease models as well as the effect of different drug candidates can be evaluated.

Can’t find what you are looking for? We are constantly establishing new tests and would be happy to develop tests according to your requirements.

In Vitro Services

QPS Neuropharmacology provides research services with numerous standardized cell culture systems including transgenic and non-transgenic cell lines, glial cells, primary chicken and rat peripheral and central nervous system neurons of different developmental stages and organotypic brain slices. New models are developed and validated on request.
LEARN MORE

In Vivo Services

As a leading CRO for CNS drug development, QPS Neuropharmacology is the premier provider for services with transgenic animals. We have more than 20 years of experience in generating, characterizing, and maintaining transgenic disease models and applying them for drug testing projects.
LEARN MORE

Ex Vivo Services

QPS Neuropharmacology's expertise lies within the field of neurodegenerative diseases. We provide a state of the art research environment (AAALAC certified) for testing and evaluating new potential treatment approaches.
LEARN MORE

Biobank

QPS Neuropharmacology's well characterized and validated in vivo models are useful tools to push your CNS drug discovery research forward. We are happy to support your research activities with sample material from our biobank composed of various specimen derived from our in-house in vivo models.
LEARN MORE

animal models

QPS Neuropharmacology is highly experienced in generating, characterizing, and maintaining transgenic disease models and using them for drug testing projects for more than 20 years.
LEARN MORE

behavioral testing

QPS Neuropharmacology provides a wide range of behavioral tests for various indications. Most tests are evaluated using rater-independent digital animal tracking systems.
LEARN MORE

histology services

QPS Neuropharmacology offers a full set of histology services ranging from collection of tissue samples to delivering study reports that contain all experimental procedures and their outcome.
LEARN MORE

biomarkers

QPS Neuropharmacology Department of Translational Medicine offers a selection of molecular biological methods for the investigation of various diseases. The unit supports in vitro and in vivo studies performed at QPS Austria.
LEARN MORE